Correlation Between GlaxoSmithKline PLC and Kinea Securities

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Kinea Securities at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Kinea Securities into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Kinea Securities Fundo, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Kinea Securities and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Kinea Securities. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Kinea Securities.

Diversification Opportunities for GlaxoSmithKline PLC and Kinea Securities

0.82
  Correlation Coefficient

Very poor diversification

The 3 months correlation between GlaxoSmithKline and Kinea is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Kinea Securities Fundo in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kinea Securities Fundo and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Kinea Securities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kinea Securities Fundo has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Kinea Securities go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and Kinea Securities

Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the Kinea Securities. In addition to that, GlaxoSmithKline PLC is 1.66 times more volatile than Kinea Securities Fundo. It trades about -0.3 of its total potential returns per unit of risk. Kinea Securities Fundo is currently generating about -0.23 per unit of volatility. If you would invest  878.00  in Kinea Securities Fundo on August 30, 2024 and sell it today you would lose (34.00) from holding Kinea Securities Fundo or give up 3.87% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy91.3%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  Kinea Securities Fundo

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Kinea Securities Fundo 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kinea Securities Fundo has generated negative risk-adjusted returns adding no value to fund investors. Despite latest weak performance, the Fund's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors.

GlaxoSmithKline PLC and Kinea Securities Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and Kinea Securities

The main advantage of trading using opposite GlaxoSmithKline PLC and Kinea Securities positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Kinea Securities can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kinea Securities will offset losses from the drop in Kinea Securities' long position.
The idea behind GlaxoSmithKline PLC ADR and Kinea Securities Fundo pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
Commodity Directory
Find actively traded commodities issued by global exchanges
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope